Improvement in Medication Adherence Through the Implementation of Personalized Nudges
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Medication Adherence
- Sponsor
- Intermountain Health Care, Inc.
- Enrollment
- 186
- Locations
- 1
- Primary Endpoint
- Adherence with taking prescribed statin medications.
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
This study will determine whether a complex, data-driven protocol for assessing patient needs and providing "nudges" (reminders to be adherent with medication prescriptions) improves adherence with cardiovascular medications. This will be accomplished by performing a 12-month clinical trial of patients with an indication for statin therapy. Participants will be randomized to either an intervention or standard-of-care arm and will be followed via passive electronic means to determine if they are adherent with medication prescriptions.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Indication for statin therapy (regardless of statin use history), either: 1) the presence of coronary artery disease (CAD) (either a new diagnosis or prior diagnosis), 2) low-density lipoprotein cholesterol (LDL-C) ≥190 mg/dL, 3) the presence of diabetes and LDL-C of 70-189 mg/dL in patients aged 40- 75 years, or 4) CAD-free and diabetes-free patients aged 40-75 years who have LDL-C 70-189 mg/dL and an estimated 10-year risk of CAD ≥7.5% based on the Pooled Cohort Risk Equations (http://my.americanheart.org/professional/StatementsGuidelines/Prevention Guidelines/Prevention-Guidelines_UCM_457698_SubHomePage.jsp)
- •Enrollment in a SelectHealth insurance plan
- •Age ≥18 years
- •Planned discharge to home
Exclusion Criteria
- •Age \<18 years
- •Alzheimers/Dementia
- •Receipt of or expected receipt of palliative care or discharge to hospice, skilled nursing facility, inpatient rehabilitation, or long-term care facility
- •Any contraindication to statin agents
Outcomes
Primary Outcomes
Adherence with taking prescribed statin medications.
Time Frame: 12 (±1) months
Adherence will be measured by examining the passively-collected data regarding the filling and refilling of the subject's prescriptions that are available electronically through SelectHealth data and calculating the proportion of time during the followup period that each subject had medication (number of days in which the medication was available after a prescription was filled divided by the total length of the follow-up period).
Secondary Outcomes
- Proportion of adherent subjects per group(12 (±1) months)
- Adherence with taking all cardiovascular medications.(12 (±1) months)
- Adherence with taking the composite of all CV medications at interim timepoints(3 months, 6 months, 9 months)
- Adherence with taking other individual cardiovascular medications.(12 (±1) months)
- Clinical Endpoints(12 (±1) months)
- Adherence with taking individual medications at interim timepoints(3 months, 6 months, 9 months)